9 insiders reported 31 Form 4 transactions for Cue Biopharma, Inc. (CUE) over the past 18 months (most recent 2026-08-28). Recent activity: Garzone Pamela (Director) Buy 18,900 shares, Sarraf Pasha (Director) Buy 18,400 shares, Ray Sumita (Chief Legal Compliance Officer) Buy 18,196 shares, Meluzio Michael Vincent (VP, Prin. Accounting Officer) Buy 13,647 shares, Ray Sumita (Chief Legal Compliance Officer) Sell 2,383 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-28 | Garzone Pamela | Director | Buy | 18,900 | $0 |
| 2026-08-28 | Sarraf Pasha | Director | Buy | 18,400 | $0 |
| 2026-08-17 | Ray Sumita | Chief Legal Compliance Officer | Buy | 18,196 | $0 |
| 2026-08-17 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | Buy | 13,647 | $0 |
| 2026-08-17 | Ray Sumita | Chief Legal Compliance Officer | Sell | 2,383 | $69,989 |
| 2026-08-17 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | Sell | 1,519 | $44,613 |
| 2026-08-17 | Ray Sumita | Chief Legal Compliance Officer | Sell | 6,442 | $195,515 |
| 2026-08-17 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | Sell | 4,106 | $124,617 |
| 2026-08-17 | Ray Sumita | Chief Legal Compliance Officer | Sell | 4 | $125 |
| 2026-08-17 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | Sell | 3 | $93 |
| 2026-08-14 | Lin Shao-Lee | Chief Executive Officer | Sell | 5,775 | $160,256 |
| 2026-08-14 | Lin Shao-Lee | Chief Executive Officer | Sell | 34,225 | $923,733 |
| 2026-08-14 | Lin Shao-Lee | Chief Executive Officer | Buy | 109,179 | $0 |
| 2026-08-14 | Lin Shao-Lee | Chief Executive Officer | Sell | 5,423 | $147,451 |
| 2026-08-14 | Lin Shao-Lee | Chief Executive Officer | Sell | 2,375 | $66,761 |
| 2026-08-14 | Lin Shao-Lee | Chief Executive Officer | Sell | 10,460 | $308,361 |
| 2026-08-03 | Ahlers James M | Chief Financial Officer | Buy | 25,500 | $0 |
| 2026-07-15 | Borie Dominique Christian | Chief Medical Officer | Buy | 31,500 | $0 |
| 2026-07-10 | Ray Sumita | Chief Legal Compliance Officer | Buy | 54,589 | $0 |
| 2026-07-10 | Lin Shao-Lee | Chief Executive Officer | Buy | 327,537 | $0 |
| 2026-07-10 | Camardo Daniel A. | Director | Buy | 21,800 | $0 |
| 2026-07-10 | Garzone Pamela | Director | Buy | 21,800 | $0 |
| 2026-07-10 | Sarraf Pasha | Director | Buy | 21,800 | $0 |
| 2026-07-10 | Meehan Viola Mong | Director | Buy | 21,800 | $0 |
| 2026-07-10 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | Buy | 40,942 | $0 |
Source: SEC Form 4 filings · as of 2026-08-28